Joel W Neal

39PUBLICATIONS
307CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMedical molecular engineering of nucleic acids and proteinsSocial program evaluation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (39)

|Oct 02, 2026
SUNRAY-02: a study of olomorasib combined with immunotherapy in stage II-III KRAS G12C-mutant non-small cell lung cancer after definitive therapy.

|Jul 21, 2026
Tobacco Use and Cessation Patterns Among Cancer Survivors: Results From Nine ECOG-ACRIN Cancer Research Group Trials.

|Apr 27, 2026
Air pollution and the risk of second primary lung cancer among lung cancer survivors: the prospective UK Biobank cohort study.

|Apr 10, 2026
First-Line Sacituzumab Govitecan Plus Pembrolizumab and Carboplatin in Metastatic Non-Small Cell Lung Cancer: Nonsquamous and Squamous Cohorts of the EVOKE-02 Study.

Jhanelle E Gray, Joel W Neal, Jyoti D Patel

|Apr 09, 2026
Evaluating Tumor Burden as a Predictive Biomarker for Epidermal Growth Factor Receptor Targeted Kinase Inhibitor Therapy in Advanced Non-Small Cell Lung Cancer.

Rika Terashima, Judy Fan, Fatma Gunturkun

|Mar 30, 2026
Clinicogenomic Characteristics and Treatment Outcomes of Patients With Advanced ALK-Rearranged Squamous and Adenosquamous Non-Small Cell Lung Cancers.

Emily A Miao, Beow Yeap, Sameh Daher

Pageof 7

Frequent Collaborators

11 joint publications

Heather Wakelee

7 joint publications

Summer S Han

6 joint publications

Eunji Choi

4 joint publications

Julie Wu